Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 17, 2018 | Shanghai Cell Therapy Group | $134.1M Series C | China Industrial Asset Management, Haier Capital | Anting People's Government, Legend Capital, Ningbo Yuanhui |